Haleon plc (HLN)
NYSE: HLN · Real-Time Price · USD
9.81
-0.13 (-1.26%)
Aug 12, 2026, 12:58 PM EDT - Market open
Haleon Market Cap
Haleon has a market cap or net worth of $42.82 billion as of August 12, 2026. Its market cap has increased by 0.84% in one year.
Market Cap
42.82B
Enterprise Value
52.93B
1-Year Change
0.84%
Ranking
Category
Stock Price
$9.81
ChartMarket Cap Chart
Since July 18, 2022, Haleon's market cap has increased from $34.14B to $42.82B, an increase of 25.40%. That is a compound annual growth rate of 5.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 42.82B | -4.70% |
| Dec 31, 2025 | 44.93B | 5.03% |
| Dec 31, 2024 | 42.77B | 13.06% |
| Dec 29, 2023 | 37.83B | 3.87% |
| Dec 30, 2022 | 36.42B | 6.67% |
| Jul 18, 2022 | 34.14B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Takeda Pharmaceutical Company | 56.09B |
| Teva Pharmaceutical Industries | 42.32B |
| Zoetis | 30.90B |
| United Therapeutics | 22.64B |
| Viatris | 18.62B |
| Neurocrine Biosciences | 16.50B |
| Elanco Animal Health | 11.33B |
| Dr. Reddy's Laboratories | 10.52B |